Glaucoma research keeps circling back to cannabis compounds. A new study published Nov. 10 in the European Journal of Pharmacology tested a water-soluble CBD eye drop in mice genetically predisposed to glaucoma, The Marijuana Herald reports. The work came from researchers affiliated with Rey Juan Carlos University in Spain.
Here's the twist: CBD first caused a temporary increase in eye pressure. With continued use, though, pressure dropped significantly and stayed down in the glaucoma-prone mice, with the strongest effect from twice-daily drops. Untreated eyes in the same animals showed smaller, inconsistent changes, suggesting the effect was local to the treated eye.
The drops also made the cornea less sensitive, an effect that lasted after treatment stopped, while eye pressure bounced back once CBD was withdrawn. Tear production and body weight didn't change.
Two caveats worth knowing: this was a mouse study, and it was funded by Laboratoire Laredo, which holds a European patent on the formulation tested. Elevated eye pressure is the main risk factor doctors can treat in glaucoma, the outlet notes.
What it means for travelers: This is early lab science, not a reason to put any CBD product in your eyes. If you have glaucoma, keep using what your eye doctor prescribed and ask them about the research.






